The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Le nouveau-ne atteint de spherocytose hereditaire risque de developper une anemie severe liee a l'incapacite de la moelle osseuse a compenser l'hyperhemolyse. Ces specificites physiopathologiques, propres a la periode neonatale, expliquent pourquoi un traitement par erythropoietine a ete propose comme alternative aux transfusions.Observation. - Nous rapportons le cas d'un nouveau-ne chez lequel une...
Le recours a la transfusion en neonatologie a ete reduit mais non supprime depuis l'utilisation de l'erythropoietine recombinante humaine.Objectifs. - 1)<space>Analyse du recours a la transfusion dans une population de prematures traites precocement par erythropoietine recombinante humaine (750<space>U/kg par semaine) et recevant une supplementation martiale precoce par voie intraveineuse...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.